Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir

Entecavir requires long-term administration. Pegylated interferon (PEG-IFN) therapy leads to significant reduction of hepatitis B surface antigen (HBs Ag) levels. This study aimed to assess the safety and efficacy of adding PEG-IFN-α-2a to entecavir toward cessation of entecavir. A total of 23 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamai, Hideyuki, Ida, Yoshiyuki, Shingaki, Naoki, Shimizu, Ryo, Fukatsu, Kazuhiro, Itonaga, Masahiro, Yoshida, Takeichi, Maeda, Yoshimasa, Moribata, Kosaku, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Kitano, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405394/
https://www.ncbi.nlm.nih.gov/pubmed/28487770
http://dx.doi.org/10.1155/2017/2093847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405394/
https://www.ncbi.nlm.nih.gov/pubmed/28487770
http://dx.doi.org/10.1155/2017/2093847

Ejemplares similares